Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole in Stasis Dermatitis
NCT04091087Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2020
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
A Phase 2 trial of AN2728 ointment vehicle in Stasis Dermatitis (SD), sponsored by Pfizer. Started Jun 2020; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
Stasis Dermatitis (SD)
Beyond the preview
Go deeper on NCT04091087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04091087.